EN
HI
Alkem Laboratories Share price
ALKEM
536818.00 (0.34%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 25 Aug, 2026, Alkem Laboratories stock price is ₹5368. During the trading session, the stock has moved between an intraday low of ₹5297.00 and an intraday high of ₹5378.00. Over the last 52 weeks, Alkem Laboratories has traded between ₹5075.00 and ₹5933.50.
The stock has recorded a trading volume of 48,065 shares, with a market capitalization of ₹119565000. Its Average Traded Price (ATP) is ₹5319.61, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 7 @ ₹5368.00.
Alkem Laboratories has an upper circuit limit of ₹5885.00 and a lower circuit limit of ₹4815.00. The total value traded stands at ₹25.57 CR, and the delivery percentage for the day is 56.21%.
The stock is currently traded with a market lot size of 1. Alkem Laboratories also offers a dividend yield of 0.99%.
Alkem Laboratories share price chart
Alkem Laboratories Share Key Metrics
Volume
48065.00
Market Cap
64182.49 CR
LTQ@LTP
7@5368.00
ATP
5319.61
Var Margin
12.5 %
Circuit Range
4815-5885
Delivery %
56.21 %
Value
25.57 CR
ASM/GSM
No
Market Lot
1
Alkem Laboratories Resistance and Support
Pivot 5355
Resistance
First Resistance
5395
Second Resistance
5440
Third Resistance
5480
Support
First Support
5310
Second Support
5270
Third Support
5225
Alkem Laboratories Futures & Options
5368
18 (0.34%)
Alkem Laboratories Option Chain
View Price, OI, Greeks & More...
25AUG26
5302.50
-30.50 (0.57%)
29SEP26
5345.50
-19.50 (0.36%)
27OCT26
5400.00
-12.00 (0.22%)
ALKEM|25AUG26 CE 5350.00
11.45
-16.2 (-58.59%)
ALKEM|25AUG26 PE 5400.00
70
-6.4 (-8.38%)
Alkem Laboratories Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
49.7%
Mutual Fund
16.71%
Insurance
4.13%
Foreign Institutional Investors
10.41%
Domestic Institutional Investors
1.79%
Retail
17.25%
Others
0.01%
Total Promoters
MAR '26
51.2%
JUN '26
49.7%
Alkem Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results & Interim Dividend |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-07 | Quarterly Results & Interim Dividend |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-08-07 | 2026-08-07 | View More |
Alkem Laboratories News
Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
Alkem Laboratories shareholders approved the scheme of amalgamation with Adroit Biomed Limited, with 99.9999% votes cast in favor. This approval follows the NCLT Mumbai's order, facilitating the merger process.
Aug 17 2026 19:02:27
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Alkem Labs announced the audio recording of its Q1 FY27 Earnings Conference Call is available on the company's website. This provides investors access to the detailed discussion and insights from the call.
Aug 14 2026 19:14:25
Alkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of Board Meeting Dated 14/08/2026
Alkem Laboratories reported Q1 FY27 consolidated revenue of ₹3,740.15 cr, a 10.95% YoY increase. However, consolidated net profit decreased by 22.00% YoY to ₹520.98 cr for the quarter.
Aug 14 2026 13:48:01
Read More
Alkem Laboratories Management
| Name | Position |
|---|---|
| Neela Bhattacherjee | Non Executive Independent Director |
| Manish Narang | President – Legal, Company Secretary & Compliance Officer |
Alkem Laboratories Similar Stocks
Aurobindo Pharma Ltd.
1617.80
9.80 (0.61%)
Fortis Healthcare Ltd.
923.95
5.95 (0.65%)
Biocon Ltd.
417.20
7.80 (1.91%)
Aster DM Quality Care Ltd.
765.25
14.35 (1.91%)
Glenmark Pharmaceuticals Ltd.
2400.00
9.30 (0.39%)
Abbott India Ltd.
26415.00
-5.00 (0.02%)
Glaxosmithkline Pharmaceuticals Ltd.
2963.40
31.70 (1.08%)
Anthem Biosciences Ltd.
874.70
-8.65 (0.98%)
Ipca Laboratories Ltd.
1928.50
8.10 (0.42%)
Gland Pharma Ltd.
2824.60
23.00 (0.82%)
Alkem Laboratories FAQs
The Buying Price of Alkem Laboratories share is 5368 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alkem Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alkem Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alkem Laboratories shares is 29.67. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alkem Laboratories shares is 4.47. Useful to assess the stock's value relative to its book value.
To assess Alkem Laboratories’s valuation compare Sector P/E, P/B which are 69.22 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alkem Laboratories is 64182.49 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alkem Laboratories share price is 5933.50 & 5075.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alkem Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in ALKEM
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC